Regulatory
PHIO
Oct 13
▲ +0.20
Phio Pharmaceuticals released its first cGMP batch of PH-762, the active ingredient for its skin cancer treatment, supporting supply chain readiness for a Phase 2b trial planned fo…
Regulatory
SABS
Oct 13
▲ +0.50
SAB Biotherapeutics received FDA Fast Track designation for its T1D candidate SAB-142. The designation aims to expedite the review process for the registrational Phase 2b study.
Regulatory
ORBS
Oct 13
▲ +0.60
Eightco Holdings Inc. notified Nasdaq that the minimum bid price for its 'ORBS' shares met the $1.00 requirement over the last 10 consecutive business days, effectively closing a c…
Regulatory
ONCY
Oct 13
▲ +0.30
Oncolytics Biotech Inc has secured new patent protection for pelareorep worldwide and obtained a method-of-use patent for its immunotherapy, with U.S. issuance expected soon and ne…
Regulatory
XTIA
Oct 13
▲ +0.30
XTI Aerospace completed an internal review finding no financial misstatements and expects to file its Q2 10-Q by October 26, 2026. The company anticipates Q2 revenue of $32.4 milli…
Regulatory
SSRM
Oct 13
▲ +0.20
SLR International consented to the filing of a technical report summary for SSR Mining's Nevada Marigold Complex, which is intended for use in SEC filings.
Regulatory
LSPT
Oct 9
— 0.00
Launch Two Acquisition Corp. announced an amendment to extend its deadline to complete a business combination, ensuring time for potential extension options up to September 2027.
Regulatory
XRAY
Oct 9
— +0.10
DENTSPLY SIRONA Inc. executed a third amendment to its Credit Agreement on Sept. 30, 2026, to delete and add specific contractual provisions, contingent upon the satisfaction of ce…
Regulatory
CTT
Oct 9
— 0.00
Holt & Patterson confirms it agrees as the predecessor auditor with CTT Pharmaceutical's disclosure in its October 2, 2026 Form 8-K regarding the transition of retained audit files…
Regulatory
ACH
Oct 9
▼ -0.60
Accendra Health received a notice from NYSE that its stock has fallen below $1 per share for 30 consecutive days. The company plans to cure the issue in the next six months, potent…
Regulatory
BAWL
Oct 9
— +0.10
Baldwin Insurance Group filed an 8-K to incorporate an independent auditor report into related filings. Approval of the report on the financial statements of Cobbs Allen Capital Ho…
Regulatory
OFA GROUP
Oct 9
— 0.00
OFA Group adopted a fourth amended and restated memorandum of association increasing authorized share capital to US$22.52 million, taking effect on October 5, 2026.
Regulatory
Federal
Oct 9
— 0.00
The Federal Reserve Board published the 2025 Survey of Consumer Finances, offering policymakers and the public detailed insights into the economic condition of American families.
Regulatory
ITP
Oct 9
▲ +0.20
IT Tech Packaging received a 12-month extension until April 15, 2027, to file delayed SEC reports after admitting NYSE non-compliance due to missing filings.
Regulatory
PRU
Oct 9
▼ -0.50
The FSA extended the suspension period for Prudential of Japan until January 31, 2027, and ordered business improvement plans. Markets will focus on the financial impact and path f…
Regulatory
Federal
Oct 8
▼ -0.60
The Federal Reserve Board announced an enforcement action against American Express Company, citing the firm's failure to sufficiently detect and report suspicious activities relate…
Regulatory
NUV
Oct 8
▲ +0.30
The Nuveen Municipal Value Fund adopted a new policy requiring that at least 80% of assets be invested in income-generating municipal bonds. This policy aligns with the fund’…
Regulatory
F · FC · FCACY
Oct 8
— 0.00
The Ford Credit Floorplan Master Owner Trust A filed a current report on October 6, 2026. No significant financial or market-moving details were specified in the provided text.
Regulatory
VIR
Oct 8
▲ +0.60
VIR-5500, a PSMA-targeted T-cell engager, has been granted Fast Track designation for late-line metastatic castration-resistant prostate cancer. The designation reflects unmet medi…
Regulatory
BIAF · BIAFW
Oct 8
▲ +0.60
bioAffinity Technologies received a notice of allowance for a Japanese patent covering its CyPath Lung test, expanding its intellectual property and protecting the noninvasive lung…